CIK 0000748592
- Non-accelerated filer
- Smaller reporting company
Ernexa Therapeutics Inc.
Sign in to watch- Ticker
- ERNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 311103425
- Phone
- +1 617-798-6700
- Business address
- 1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
- Former names
- Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC
Securities
- ERNA Common Stock Nasdaq
- ERNAW Warrants Nasdaq
- RW Other RW
- 8-A12B/A Other Registration Statement
- CERT Other Certification
- 8-A12B Other Registration of Securities
- 25 Other Notification of Removal from Listing
- S-8 Other Securities Offered to Employees in Benefit Plans
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- EFFECT Other Notice of Effectiveness
- S-8 Other Securities Offered to Employees in Benefit Plans
- EFFECT Other Notice of Effectiveness
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- EFFECT Other Notice of Effectiveness
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- S-8 Other Securities Offered to Employees in Benefit Plans
- DEFR14A Other DEFR14A
- DEFR14A Other DEFR14A
Page 3 of 6 · 108 filings